Haloperidol Decanoate 200 mg Total Dose Administration
For a total dose of 200 mg haloperidol decanoate, administer as two separate injections: 100 mg initially, followed by the remaining 100 mg in 3-7 days 1.
Dosing Rationale and FDA Guidance
The FDA-approved labeling explicitly states that the initial dose of haloperidol decanoate should not exceed 100 mg regardless of previous antipsychotic dose requirements 1. When conversion calculations indicate a need for more than 100 mg as an initial dose, the protocol is clear:
- Maximum first injection: 100 mg
- Second injection: Remaining balance (in this case, 100 mg)
- Timing between injections: 3-7 days
This split-dosing approach minimizes the risk of overdosage during the initial period of dose adjustment while allowing for close clinical supervision 1.
Administration Technique
- Route: Deep intramuscular injection only (DO NOT ADMINISTER INTRAVENOUSLY)
- Needle size: 21 gauge recommended
- Maximum volume per injection site: 3 mL
- Inspection: Visually inspect for particulate matter and discoloration before administration 1
Critical Safety Considerations
Close clinical supervision is required during the initial period of dose adjustment to minimize risks of:
- Overdosage
- Reappearance of psychotic symptoms before the next injection 1
Prerequisites Before Initiating Decanoate
Patients must be:
- Previously stabilized on antipsychotic medication
- Treated with and tolerating short-acting haloperidol well (to reduce risk of unexpected adverse sensitivity) 1
Supplementation During Adjustment
During dose adjustment or episodes of symptom exacerbation, haloperidol decanoate therapy can be supplemented with short-acting forms of haloperidol 1. This allows for more flexible symptom management while the long-acting formulation reaches steady state.
Maintenance Scheduling
After the initial loading period, haloperidol decanoate is usually administered monthly or every 4 weeks, though variation in patient response may require adjustment of both dosing interval and dose 1. Clinical experience with doses greater than 450 mg per month is limited 1.